Holen Sie sich die Stockscreener-App
26.81
0.30%
-0.08
Vorhandelsmarkt:
26.55
-0.26
-0.97%
Acadia Pharmaceuticals Inc Aktie (ACAD) Neueste Nachrichten
What drives ACADIA Pharmaceuticals Inc stock priceReal Estate Investment Trusts & Affordable Market Investment - earlytimes.in
Norges Bank Invests $31.68 Million in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
(ACAD) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Marshall Wace LLP Purchases 1,639,315 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Swing Trade: Can ACADIA Pharmaceuticals Inc stock maintain growth trajectoryJuly 2025 Short Interest & Verified Stock Trade Ideas - BỘ NỘI VỤ
Assessing ACADIA Pharmaceuticals Valuation After Strong 2024 Share Price Rally - Yahoo Finance
MACD Signal: Is ACADIA Pharmaceuticals Inc stock a buy in volatile marketsJuly 2025 Market Mood & Community Consensus Trade Signals - BỘ NỘI VỤ
ACADIA Pharmaceuticals (ACAD) Is Up 9.6% After Earnings Beat And NUPLAZID Patent Extension News - Yahoo Finance
Assessing Acadia Pharmaceuticals (ACAD) Valuation After Strong Q3 Results and Extended NUPLAZID Patent Protection - Yahoo Finance
State Board of Administration of Florida Retirement System Increases Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals (ACAD) Receives a Buy from UBS - The Globe and Mail
ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 12-Month HighShould You Buy? - MarketBeat
Why Is Acadia (ACAD) Up 22.6% Since Last Earnings Report? - sharewise.com
Is ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Recent Stock Performance Tethered To Its Strong Fundamentals? - 富途牛牛
Stonepine Capital Management LLC Has $4.85 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Acadia Pharmaceuticals stock hits 52-week high at 26.65 USD By Investing.com - Investing.com Nigeria
Fisher Asset Management LLC Sells 44,710 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Edgestream Partners L.P. Sells 47,964 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Is ACADIA Pharmaceuticals Inc. stock safe for conservative investorsQuarterly Performance Summary & Weekly High Return Stock Opportunities - Newser
Buy Acadia Pharmaceuticals For Daybue/Nuplazid Stability And Pipeline Optionality (ACAD) - Seeking Alpha
Acadia Pharmaceuticals stock hits 52-week high at 26.65 USD - Investing.com India
UBS Adjusts ACADIA Pharmaceuticals Price Target to $35 From $39, Maintains Buy Rating - marketscreener.com
Acadia Pharmaceuticals stock price target lowered to $35 at UBS By Investing.com - Investing.com UK
Can ACADIA Pharmaceuticals Inc. stock maintain operating margins2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
ACADIA Pharmaceuticals Earnings Notes - Trefis
ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts - Yahoo Finance
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - The Motley Fool
Acadia to pivot to Alzheimer’s psychosis pipeline, accd to Wall Street analysts - Yahoo Finance UK
Capital Fund Management S.A. Reduces Stock Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
How ACADIA Pharmaceuticals Inc. stock benefits from tech adoption2025 Trading Volume Trends & AI Driven Stock Price Forecasts - Newser
ACADIA Pharmaceuticals (ACAD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Mizuho Maintains 'Neutral' Rating on ACAD, Raises Price Target t - GuruFocus
Acadia Pharmaceuticals stock price target raised by Mizuho to $29 - Investing.com Canada
ACADIA Pharmaceuticals Inc Stock Analysis and ForecastCurrency Fluctuation Impact & Free Trading Psychology Sessions - earlytimes.in
F m Investments LLC Lowers Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Ensign Peak Advisors Inc Cuts Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
American Century Companies Inc. Sells 65,361 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Is ACADIA Pharmaceuticals Inc a good long term investmentEvening Star Patterns & High Profit Growth Stocks - earlytimes.in
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock - MSN
Summit Global Investments Reduces Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Prudential Financial Inc. Raises Stock Holdings in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
(ACAD) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Stocks Flashing Renewed Technical Strength: ACADIA Pharmaceuticals - Investor's Business Daily
Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study - Springer
Geode Capital Management LLC Buys 69,584 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LSV Asset Management Increases Position in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals Inc. (ACAD) Options Chain - Yahoo! Finance Canada
Acadia Pharmaceuticals Reports Strong Q3 2025 Growth - MSN
How ACADIA Pharmaceuticals Inc. stock trades before earningsInsider Buying & Real-Time Market Trend Scan - newser.com
Acadia Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference - BioSpace
Is ACADIA Pharmaceuticals Inc. stock oversold or undervalued2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
Parkinson's Disease Psychosis Market Size (7MM) was ~USD 665 - openPR.com
Will ACADIA Pharmaceuticals Inc. stock split again soonShare Buyback & Verified Entry Point Detection - newser.com
[Form 4] ACADIA PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
CFO Schneyer Acquires 9,564 Of Acadia Pharmaceuticals Inc [ACAD] - TradingView
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):